Prior investigations in Chile among individuals with a personal or familial history of breast and ovarian cancer have revealed varying frequencies of pathogenic (P) variants in BRCA1/2, ranging between 7% and 17% [5–14]. Here, BRCA1 is linked to ovarian cancer.